SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Dino's Bar & Grill

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Goose94 who wrote (62151)7/12/2019 8:07:15 AM
From: Goose94Read Replies (1) of 202923
 
CannTrustâ„¢ Holdings (TRST-T) continued to decline Thirst-day after a ninth analyst downgraded the stock. Analysts have downgraded the stock as a result of a regulatory breach that meant the company had to stop selling cannabis grown in unlicensed rooms.

Canaccord Genuity analyst Derek Dley cut his rating to "hold" from "speculative buy" and he slashed his share target to $5 from $12. Analysts on average target the shares at $9.60.

Mr. Dley says in a note: "Clearly, the major concern among investors at this point is whether Health Canada will look to make an example out of Canntrust and potentially pull the company's production license. While we had originally viewed this as highly unlikely, we are now acknowledging this could be within the realm of possibility."

Oct. 12, 2018, that Beacon Securities analyst Russell Stanley said Canntrust was "one of a handful of producers positioned to excel." He began coverage with a "buy" rating and $21 share target. The shares were then worth $13.30.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext